Company
Less noise means more discovery: Jumpcode Genomics CRISPRclean technology removes the noise—so you can easily find the genetic information you care about.
At Jumpcode Genomics, we are focused on breaking the technical barriers limiting genomics today. Our patented technology unlocks the power of next-generation sequencing by improving sensitivity, reducing costs, simplifying workflows and removing bias. We are empowering scientists to extract greater insights and detect novel signals that were previously hidden by abundant and uninformative sequences. Researchers worldwide are using Jumpcode’s CRISPRclean technology in the fields of basic research, infectious disease, oncology and consumer genomics.
Leadership
Our leadership team is passionate about what we do and who we are as a company. They are proven life-science leaders with experience and connections across the industry and in the global scientific community.
Mike Salter
CEO
Mike joins Jumpcode from EKF Diagnostics a Global Medical Device company where he held the position of CEO. Previously Mike worked at GE Healthcare where he was General Manager of the global Molecular reagents and services business. He spent a total of 33 years with GE and Amersham in a variety of positions in the UK, Canada and the USA. Mike brings with him over 39 years of experience in the Life Sciences and Diagnostics business.
John Estill
Director, Finance
Director, Finance
Lee Lieberman
Director, Business Development
Director, Business Development
Azeem Siddique
Director, Research and Development
Director, Research and Development
Sridhar Ranganathan
Director, Bioinformatics
Director, Bioinformatics
Board Members
Mike Salter
CEO/President
Frank Witney
Chair/Independent
Kirk Malloy
Independent
Dan Kidle
Arboretum Ventures
Court Turner
Lyzz Capital
Scientific Advisory Board
Gene Yeo
UCSD
Shawn Levy
Element Bio
Stan Nelson
UCLA
Nik Schork
TGen
Andrew Su
Scripps